Induction of high mobility group I architectural transcription factors in proliferating vascular smooth muscle in vivo and in vitro

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 12, 1999, Pages 2199-2205

  Chin, Michael T ^a,b,c   Pellacani, Andrea ^a   Hsieh, Chung Ming ^a   Lin, Sharon S J ^a   Jain, Mukesh K ^a,b,c   Patel, Anand ^a   Huggins, Gordon S ^a,d   Reeves, Raymond ^e   Perrella, Mark A ^a,b,c   Lee, Mu En ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Arteriosclerosis; Restenosis; Vascular injury

Indexed keywords

HIGH MOBILITY GROUP PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTICLE; CAROTID ARTERY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INTIMA; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALIA;

EID: 0033378423     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.1054     Document Type: Article

References (32)

1. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell. 82:1995;57-65.
2. Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, Fusco A. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol. 15:1995;1545-1553.
3. Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol. 54:1996;35-100.
4. Chin MT, Pellacani A, Wang H, Lin SS, Jain MK, Perrella MA, Lee ME. Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y). J Biol Chem. 273:1998;9755-9760.
5. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
6. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. Lab Invest. 49:1983;327-333.
7. Friedmann M, Holth LT, Zoghbi HY, Reeves R. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res. 21:1993;4259-4267.
8. Giancotti V, Pani B, D'Andrea P, Berlingieri MT, Di Fiore PP, Fusco A, Vecchio G, Philp R, Crane-Robinson C, Nicolas RH, Wright CA, Goodwin GH. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by cotransfection with c-myc and polyoma middle T genes. EMBO J. 6:1987;1981-1987.
9. Gunther S, Alexander RW, Atkinson WJ, Gimbrone MA. Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol. 92:1982;289-298.
10. Hsieh C-M, Yoshizumi M, Endege WO, Kho C-J, Jain MK, Kashiki S, de los Santos R, Lee W-S, Perrella MA, Lee M-E. APEG-1, a novel gene preferentially expressed in aortic smooth muscle cells, is down-regulated by vascular injury. J Biol Chem. 271:1996;17354-17359.
11. Jain MK, Fujita KP, Hsieh CM, Endege WO, Sibinga NE, Yet SF, Kashiki S, Lee WS, Perrella MA, Haber E, Lee ME. Molecular cloning and characterization of SmLIM, a developmentally regulated LIM protein preferentially expressed in aortic smooth muscle cells. J Biol Chem. 271:1996;10194-10199.
12. Johnson KR, Disney JE, Wyatt CR, Reeves R. Expression of mRNAs encoding mammalian chromosomal proteins HMG-I and HMG-Y during cellular proliferation. Exp Cell Res. 187:1990;69-76.
13. Johnson KR, Lehn DA, Elton TS, Barr PJ, Reeves R. Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). J Biol Chem. 263:1988;18338-18342.
14. Kingston RE, Bunker CA. Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev. 10:1996;905-920.
15. Lanahan A, Williams JB, Sanders LK, Nathans D. Growth factor-induced delayed early response genes. Mol Cell Biol. 12:1992;3919-3929.
16. Lehn DA, Elton TS, Johnson KR, Reeves R. A conformational study of the sequence specific binding of HMG-I(Y) with the bovine interleukin-2 cDNA. Biochem Int. 16:1988;963-971.
17. Li D, Lin HH, McMahon M, Ma H, Ann DK. Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells. J Biol Chem. 272:1997;25062-25070.
18. Manfioletti G, Giancotti V, Bandiera A, Buratti E, Sautiere P, Cary P, Crane-Robinson C, Coles B, Goodwin GH. cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res. 19:1991;6793-6797.
19. Nissen MS, Langan TA, Reeves R. Phosphorylation by cdc2 kinase modulates DNA binding activity of high mobility group I nonhistone chromatin protein. J Biol Chem. 266:1991;19945-19952.
20. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 75:1995;487-517.
21. Reeves R, Nissen MS. The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem. 265:1990;8573-8582.
22. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual. Second Edition. Plainview, New York: Cold Spring Harbor Laboratory Press, 1989. 1989.
24. Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJ. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nature Genet. 10:1995;436-444.
25. Thanos D, Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell. 83:1995;1091-1100.
26. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 76:1979;4350-4354.
27. Tsai J-C, Perrella MA, Yoshizumi M, Sibinga NES, Tan LC, Haber E, Chang THT, Schlegel R, Lee ME. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest. 97:1996;146-153.
28. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, Lee ME. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA. 91:1994;6369-6373.
29. Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M, Viglietto G, Fusco F, Verde P. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J. 16:1997;5310-5321.
30. Xiao S, Lux ML, Reeves R, Hudson TJ, Fletcher JA. HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma [comment]. Am J Pathol. 150:1997;901-910.
31. Yoshizumi M, Lee W-S, Hsieh C-M, Tsai J-C, Li J, Perrella MA, Patterson C, Endege WO, Schlegel R, Lee M-E. Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J Clin Invest. 95:1995;2275-2280.
32. Zhou X, Benson KF, Ashar HR, Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature. 376:1995;771-774.